2021-03-11 by Proactive Australia
Nanoveu Ltd s (ASX:NVU) suite of NanoshieldTM antiviral protection technologies continue to develop international momentum with further in-bound enquiries leading to a growing list of international distribution partners.
The company has executed an exclusive distribution agreement with Vital Medikal Konfeksiyon Teksil San ve Tic Ltd Sti for distribution in the Republic of Turkey, as well as a non-exclusive distribution agreement for Hong Kong with Asia Pro Lab Limited.
Shares up 45%
Investors responded positively with shares as much as 45% higher this morning to 7.2 cents.
The agreement with Vital Medikal is effective immediately for a term of 12-months and while there are no guarantees of product sales, an annual US$575,000 purchase target has been agreed for Vital Medikal to maintain exclusivity for Turkey.
Nanoveu Ltd higher as it gains further international momentum for antiviral protection technologies proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.